![]() Always do additional research and consult a professional before purchasing a security. The author has no securities or affiliations related to this organization. Information for this briefing was found via Numinus Wellness. With a wide range of features, pricing, details, and more to evaluate, choosing the right Mind Mapping Software for your business is tricky. Numinus Wellness last traded at $0.53 on the TSX. Upon closing, Novamind shareholders will hold 18% of Numinus on a post-transaction basis. Apparently, NovaMind Software has taken a page from Evernote’s playbook: Make the subscription price a no-brainer and get users hooked on using your elegantly-designed. Compared to subscription prices for other cloud-based applications, this is an excellent value. This Mind Map starts out with your central. The transaction is expected to close in June 2022, following shareholder approvals of the transaction. NovaMind’s new monthly subscription will be aggressively priced at 6.99. Pricing Novamind One low price - all the features PRICE 6 / month when billed annually (or 7 when billed monthly) all prices in USD Subscribe now There is also a free Lite subscription which allows you to create Mind Maps with up to 25 topics. Novamind enables you to quickly organize your ideas and thoughts by putting them in an interactive visual map. What’s more, as recently as January the company raised funds, at the time selling $5.0 million worth of stock at a price of $0.40 per unit to an institutional investor. Still not sure about NovaMind Check out alternatives and read real reviews from real users. ![]() With the help of Capterra, learn about NovaMind, its features, pricing information, popular comparisons to other Idea Management products and more. It didn’t sink below the $0.44 mark until well over a year later in January 22, after which it continued to fall as low as $0.18. NovaMind Pricing, Alternatives & More 2023 - Capterra. Novamind debuted on the public markets last January, opening at a price of $1.50 per share. While the premium is rather significant, it should be noted that the sales price represents a major loss to the majority of shareholders. Shareholders of Novamind are to receive 0.84 of a Numinus share for each share held, equivalent to a price per share of $0.44, which is a 51% premium to the 20-day volume weighted average price of the company. The transaction will see total consideration for Novamind to consist of $26.2 million on a fully diluted basis. Numinus’ current executive team is said to be relatively unchanged, with key personnel from Novamind entering employment agreements effective upon closing. The path to profitability is also said to be shortened, although no specifics are provided. Gross margins are estimated to be roughly 37.9% on a post-transaction basis. The firm has referred to the pro-forma offerings as a “comprehensive clinical research offering,” based on Novamind’s DEA Schedule 1 licenses for research and Numinus’ own Health Canada licenses.įrom a financial perspective, the combined entity is expected to have annual revenues of roughly $10.0 million on a pro-forma basis, while the combination is expected to result in synergies of roughly $3.0 million per year. Novamind is a mental health company enabling safe access to psychedelic medicine through a network of.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |